Cargando…

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

BACKGROUND: A single nucleotide polymorphism located in the 3'-untranslated region of the KRAS oncogene (KRAS variant; rs61764370) disrupts a let-7 miRNA binding and was recently reported to act as a genetic marker for increased risk of developing human cancers. We aimed to investigate an assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerne, Jasmina-Ziva, Stegel, Vida, Gersak, Ksenija, Novakovic, Srdjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342891/ https://www.ncbi.nlm.nih.gov/pubmed/22436609 http://dx.doi.org/10.1186/1471-2407-12-105

Ejemplares similares

Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer
por: Cerne, Jasmina-Ziva, et al.
Publicado: (2011)

SLC23A2-05 (rs4987219) and KRAS-LCS6 (rs61764370) polymorphisms in patients with squamous cell carcinoma of the head and neck
por: SANTIAGO, MARÍLIA BUENO, et al.
Publicado: (2014)

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
por: Strojnik, Ksenija, et al.
Publicado: (2021)

Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity
por: Cerkovnik, Petra, et al.
Publicado: (2010)

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma
por: Gornjec, Andreja, et al.
Publicado: (2019)

Association of Rs61764370 polymorphism within let-7 microRNA-binding site with lung cancer in Iranian population
por: Farokhzad, Neda, et al.
Publicado: (2020)

Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer
por: Vodusek, Ana Lina, et al.
Publicado: (2011)

Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection
por: Norcic, Gregor, et al.
Publicado: (2016)

An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube
por: Boltežar, Lučka, et al.
Publicado: (2020)

Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2022)

Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age
por: Cvelbar, Mirjam, et al.
Publicado: (2017)

New Approach for Detection of Normal Alternative Splicing Events and Aberrant Spliceogenic Transcripts with Long-Range PCR and Deep RNA Sequencing
por: Dragoš, Vita Šetrajčič, et al.
Publicado: (2021)

Correlation of treatment outcome in sanger/RT-qPCR KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumors with next-generation sequencing results: A single-center report
por: Unk, Mojca, et al.
Publicado: (2022)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I
por: Setrajcic Dragos, Vita, et al.
Publicado: (2019)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

The Prevalence of Occult Ovarian Cancer in the Series of 155 Consequently Operated High Risk Asymptomatic Patients – Slovenian Population Based Study
por: Gornjec, Andreja, et al.
Publicado: (2020)

Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours
por: Bombac, Alenka, et al.
Publicado: (2020)

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
por: Stegel, Vida, et al.
Publicado: (2022)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue
por: Klančar, Gašper, et al.
Publicado: (2020)

Association of Zn and Cu Levels in Cord Blood and Maternal Milk with Pregnancy Outcomes among the Slovenian Population
por: Osredkar, Joško, et al.
Publicado: (2022)

BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)

Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas?
por: Brozic, Andreja, et al.
Publicado: (2015)

Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer
por: Sellahewa, Chaminda, et al.
Publicado: (2008)

Characterization and automatic classification of preterm and term uterine records
por: Jager, Franc, et al.
Publicado: (2018)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer – a single institution retrospective analysis
por: Rebersek, Martina, et al.
Publicado: (2011)

An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer
por: von Karstedt, Silvia, et al.
Publicado: (2020)

The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
por: Chang, Kuang-Leei, et al.
Publicado: (2016)

Genetic markers for non-syndromic orofacial clefts in populations of European ancestry: a meta-analysis
por: Slavec, Lara, et al.
Publicado: (2022)

Overexpression of HER2/HER3 and clinical feature of ovarian cancer
por: Chung, Ye Won, et al.
Publicado: (2019)

Association of the rs8720 and rs12587 KRAS Gene Variants with Colorectal Cancer in a Mexican Population and Their Analysis In Silico
por: Gallegos-Arreola, Martha Patricia, et al.
Publicado: (2023)

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients
por: Zhao, Xiangshan, et al.
Publicado: (2012)

Towards comprehensive characterization of HER2 overexpression
por: Berezov, Alan, et al.
Publicado: (2006)

MicroRNA and HER2-overexpressing Cancer
por: Wang, Shizhen Emily, et al.
Publicado: (2013)

A Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease
por: Karas Kuželički, Nataša, et al.
Publicado: (2022)

The development and initial validation of the Health and Reproductive Survey (HeRS)
por: Duffy, Donna, et al.
Publicado: (2021)

Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas
por: KOKOVIC, IRA, et al.
Publicado: (2014)

Molecular Mechanisms of Gastrointestinal Stromal Tumors and Their Impact on Systemic Therapy Decision
por: Unk, Mojca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2v56acg2o90ad1ovm1l8rkukns